{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:35:35Z","timestamp":1762544135109,"version":"3.44.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03320-8","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T21:02:22Z","timestamp":1752613342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing inflammatory protein biomarkers in COPD subjects with and without alpha-1 antitrypsin deficiency"],"prefix":"10.1186","volume":"26","author":[{"given":"Matthew","family":"Moll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine A.","family":"Pratte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auyon J.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell P.","family":"Bowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Lomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin K.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn L.","family":"DeMeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"3320_CR1","doi-asserted-by":"publisher","first-page":"e069679","DOI":"10.1136\/bmj-2021-069679","volume":"378","author":"S Safiri","year":"2022","unstructured":"Safiri S, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990\u20132019: results from the Global Burden of Disease Study 2019. BMJ. 2022;378:e069679.","journal-title":"BMJ"},{"key":"3320_CR2","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1056\/NEJMcp0900449","volume":"360","author":"EK Silverman","year":"2009","unstructured":"Silverman EK, Sandhaus RA. Clinical practice. Alpha1-antitrypsin deficiency. N Engl J Med. 2009;360:2749\u201357.","journal-title":"N Engl J Med"},{"key":"3320_CR3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/thx.2006.075846","volume":"62","author":"DL Demeo","year":"2007","unstructured":"Demeo DL, et al. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. Thorax. 2007;62:806\u201313.","journal-title":"Thorax"},{"key":"3320_CR4","doi-asserted-by":"publisher","first-page":"104262","DOI":"10.1016\/j.ebiom.2022.104262","volume":"84","author":"KA Serban","year":"2022","unstructured":"Serban KA, et al. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease. EBioMedicine. 2022;84:104262.","journal-title":"EBioMedicine"},{"key":"3320_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/15412550903499522","volume":"7","author":"EA Regan","year":"2010","unstructured":"Regan EA, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7:32\u201343.","journal-title":"COPD"},{"key":"3320_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1164\/rccm.202106-1404OC","volume":"205","author":"AJ Ghosh","year":"2022","unstructured":"Ghosh AJ, et al. Alpha-1 Antitrypsin MZ heterozygosity is an endotype of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2022;205:313\u201323.","journal-title":"Am J Respir Crit Care Med"},{"key":"3320_CR7","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014;9:e95192.","journal-title":"PLoS One"},{"key":"3320_CR8","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik L, et al. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol Cell Proteomics. 2021;20:100168.","journal-title":"Mol Cell Proteomics"},{"key":"3320_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S2213-2600(21)00503-8","volume":"10","author":"WS Bowman","year":"2022","unstructured":"Bowman WS, et al. Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis. Lancet Respir Med. 2022;10:593\u2013602.","journal-title":"Lancet Respir Med"},{"key":"3320_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological). 1995;57:289\u2013300.","journal-title":"J R Stat Soc Series B (Methodological)"},{"key":"3320_CR11","doi-asserted-by":"publisher","unstructured":"Megill C, et al. cellxgene: a performant, scalable exploration platform for high dimensional sparse matrices. 2021. 2021.04.05.438318 Preprint at https:\/\/doi.org\/10.1101\/2021.04.05.438318.","DOI":"10.1101\/2021.04.05.438318"},{"key":"3320_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.","journal-title":"BMC Bioinformatics"},{"key":"3320_CR13","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90-97.","journal-title":"Nucleic Acids Res"},{"key":"3320_CR14","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie Z, et al. Gene set knowledge discovery with enrichr. Curr Protoc. 2021;1:e90.","journal-title":"Curr Protoc"},{"key":"3320_CR15","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"3320_CR16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41588-018-0342-2","volume":"51","author":"P Sakornsakolpat","year":"2019","unstructured":"Sakornsakolpat P, et al. Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations. Nat Genet. 2019;51:494\u2013505.","journal-title":"Nat Genet"},{"key":"3320_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41588-023-01314-0","volume":"55","author":"N Shrine","year":"2023","unstructured":"Shrine N, et al. Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk. Nat Genet. 2023;55:410\u201322.","journal-title":"Nat Genet"},{"key":"3320_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12890-022-01848-9","volume":"22","author":"S Sin","year":"2022","unstructured":"Sin S, Lim M, Kim J, Bak SH, Kim WJ. Association between plasma sRAGE and emphysema according to the genotypes of AGER gene. BMC Pulm Med. 2022;22:58.","journal-title":"BMC Pulm Med"},{"key":"3320_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12931-021-01686-z","volume":"22","author":"KA Pratte","year":"2021","unstructured":"Pratte KA, et al. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD. Respir Res. 2021;22:127.","journal-title":"Respir Res"},{"key":"3320_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1164\/rccm.202303-0507LE","volume":"209","author":"J Rojas-Quintero","year":"2024","unstructured":"Rojas-Quintero J, et al. Spatial transcriptomics resolve an emphysema-specific lymphoid follicle B cell signature in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2024;209:48\u201358.","journal-title":"Am J Respir Crit Care Med"},{"key":"3320_CR21","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1164\/rccm.201507-1311OC","volume":"193","author":"R Faner","year":"2016","unstructured":"Faner R, et al. Network analysis of lung transcriptomics reveals a distinct B-cell signature in emphysema. Am J Respir Crit Care Med. 2016;193:1242\u201353.","journal-title":"Am J Respir Crit Care Med"},{"key":"3320_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1165\/rcmb.2021-0503LE","volume":"66","author":"MA Campos","year":"2022","unstructured":"Campos MA, Geraghty P. Cytokine regulation by alpha-1 antitrypsin therapy: a pathway analysis of a pilot clinical trial. Am J Respir Cell Mol Biol. 2022;66:697\u2013700.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3320_CR23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1189\/jlb.0208145","volume":"85","author":"GB Pott","year":"2009","unstructured":"Pott GB, Chan ED, Dinarello CA, Shapiro L. \u03b1-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol. 2009;85:886\u201395.","journal-title":"J Leukoc Biol"},{"key":"3320_CR24","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMoa2401389","volume":"390","author":"SD Aaron","year":"2024","unstructured":"Aaron SD, et al. Early diagnosis and treatment of COPD and asthma \u2014 a randomized, controlled trial. N Engl J Med. 2024;390:2061\u201373.","journal-title":"N Engl J Med"},{"key":"3320_CR25","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jama.2024.24212","volume":"333","author":"J Zhang","year":"2025","unstructured":"Zhang J, et al. Polygenic risk score added to conventional case finding to identify undiagnosed chronic obstructive pulmonary disease. JAMA. 2025;333:784\u201392.","journal-title":"JAMA"},{"key":"3320_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMoa1104623","volume":"365","author":"RK Albert","year":"2011","unstructured":"Albert RK, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365:689\u201398.","journal-title":"N Engl J Med"},{"key":"3320_CR27","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4103\/jfmpc.jfmpc_84_17","volume":"7","author":"SC Chaudhary","year":"2018","unstructured":"Chaudhary SC, et al. Prevalence of thyroid dysfunction in chronic obstructive pulmonary disease patients in a tertiary care center in North India. J Fam Med Prim Care. 2018;7:584.","journal-title":"J Fam Med Prim Care"},{"key":"3320_CR28","doi-asserted-by":"publisher","first-page":"e0158843","DOI":"10.1371\/journal.pone.0158843","volume":"11","author":"Y-WR Chen","year":"2016","unstructured":"Chen Y-WR, Leung JM, Sin DD. A systematic review of diagnostic biomarkers of COPD exacerbation. PLoS One. 2016;11:e0158843.","journal-title":"PLoS One"},{"key":"3320_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1164\/rccm.202107-1584OC","volume":"205","author":"M Moll","year":"2022","unstructured":"Moll M, et al. Development of a blood-based transcriptional risk score for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2022;205:161\u201370.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03320-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03320-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03320-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T11:25:32Z","timestamp":1757244332000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03320-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3320"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03320-8","relation":{},"ISSN":["1465-993X"],"issn-type":[{"type":"electronic","value":"1465-993X"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent and the current study was approved by the Mass General Brigham Institutional Review Board (2007P000554).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DLD has received grant support from Bayer. EKS received grant support from Bayer and Northpond Laboratories. BDH received grant support from Bayer and is currently employed by Regeneron. MM received consulting fees from Sitka, TheaHealth, 2ndMD, TriNetX, Axon Advisors, Verona Pharma, Dialectica, Sanofi, Genentech.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"247"}}